GMP Archives | Cannabiz

‘Not for the faint hearted’: Crisci Group facility gets green light to manufacture medicinal cannabis

by Steve Jones October 16, 2026October 16, 2026

Crisci Group-owned Cann Pharma has received its manufacturing licence from the Therapeutic Goods Administration enabling it […]

‘This is just the beginning’: BLS CEO on German expansion and vision for firm

by Adam Sheldon August 6, 2026August 6, 2026

‘A great improvement’: ECS delivers fourth consecutive cash flow positive quarter

by Adam Sheldon July 20, 2026July 20, 2026

ECS Botanics: German GMP guidance could have ‘global impact’

by Adam Sheldon July 8, 2026July 8, 2026

Austranna says high-tech facility could ‘double’ Australia’s growing capacity

by Adam Sheldon June 16, 2026June 18, 2026

‘We could become a formidable force’: Cannaponics launches public capital raise

by Adam Sheldon May 13, 2026May 14, 2026

Ora Pharm buys key Helius Therapeutics assets in major NZ deal

by Adam Sheldon May 13, 2026May 13, 2026

News in brief: Puro completes first hash export; GrowerIQ renews GMP compliance; MedReleaf inks Leafio deal; Vitura forms advisory group; Althea to become Peak Processing

by Adam Sheldon December 2, 2025February 21, 2026

‘Not a revenue grab’: Curaleaf International CEO maps out Australian expansion plan

by Adam Sheldon November 27, 2025December 2, 2025

Compliance gaps, slow licensing and strict rules put Australia at risk on global stage, expert warns

by Adam Sheldon November 26, 2025November 26, 2025